Mrs. Elizabeth Cordero, R.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Carr. 4485 Km. 3.2 Bo. San Jose, Quebradillas, PR 00678 Phone: 787-232-5368 Fax: 787-895-3863 |
Ms. Juliana L Cadiz, MS Physical Therapist Medicare: Medicare Enrolled Practice Location: Hc-03 Box 18089, Quebradillas, PR 00678 Phone: 787-354-2105 |
Mrs. Lourdes Garcia Jimenez, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Linares #208 Street, Quebradillas, PR 00678 Phone: 787-895-3052 |
Mrs. Idalis Jimenez Gonzalez, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Carr #2 Km 96.7 Barrio Cocos, Quebradillas, PR 00678 Phone: 787-691-5988 Fax: 787-895-4052 |
News Archive
A new study of classical Chinese medical texts identifies references to age-related memory impairment similar to modern-day Alzheimer's disease, and to several plant-based ingredients used centuries ago - and still in use today - to treat memory impairment.
It is not primary tumors that are responsible for the majority of cancer deaths, but rather their metastases. Physiologists and neuropathologists from the University of Zurich have now identified the origin of metastasis formation, thereby becoming the first to reveal the pathway of metastasizing intestinal cancer cells out of the blood stream. The results allow new approaches in the development of cancer therapies.
ResMed, a leading manufacturer of sleep and respiratory medical equipment, today announced that it has introduced a new generation continuous positive airway pressure (CPAP) mask designed to improve the patient experience and compliance. With minimal contact on the face and a sleek design, Swift FX is expected to help sleep apnoea patients overcome issues related to wearing a mask at night and effectively providing them with a good night's sleep.
The Clinical Trials Network of Tennessee (CTN2) at the University of Tennessee Health Science Center has contracted a new clinical trial to test possible therapeutics for COVID-19 in hospitalized patients. This new trial brings the total generated by CTN2 contracts for the university to nearly $7 million.
› Verified 1 days ago